NCT00509093 2020-03-17Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received ChemotherapyCase Comprehensive Cancer CenterPhase 2 Completed32 enrolled 14 charts
NCT00450983 2017-05-24Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesFred Hutchinson Cancer CenterPhase 2 Terminated1 enrolled 5 charts
NCT00049504 2017-05-17Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled 10 charts